Discontinued ProductUnfortunately Oxprenolol hydrochloride (Cat. No. 3288) has been withdrawn from sale for commercial reasons.
Non-selective β-adrenergic antagonist.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Preparing Stock Solutions
The following data is based on the product molecular weight 301.81. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.31 mL||16.57 mL||33.13 mL|
|5 mM||0.66 mL||3.31 mL||6.63 mL|
|10 mM||0.33 mL||1.66 mL||3.31 mL|
|50 mM||0.07 mL||0.33 mL||0.66 mL|
References are publications that support the products' biological activity.
View Related Products by Product Action
Keywords: Oxprenolol hydrochloride, supplier, Non-Selective, β-adrenoceptor, beta-adrenoceptor, b-adrenoceptor, antagonists, β-adrenergic, beta-adrenergic, b-adrenergic, Receptors, Non-selective, Adrenergic, Beta, Receptors, Non-selective, Adrenergic, Beta, Receptors, Tocris Bioscience
Citations for Oxprenolol hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for Oxprenolol hydrochloride.
Reviews for Oxprenolol hydrochloride
There are currently no reviews for this product. Be the first to review Oxprenolol hydrochloride and earn rewards!
Have you used Oxprenolol hydrochloride?
Submit a review and receive an Amazon gift card.
$10US/$10CAN/€7/£6 gift card for a review without an image
$25US/$25CAN/€18/£15 gift card for a review with an image
*Offer only valid in the USA / Canada, UK and EuropeSubmit a Review
Literature in this Area
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.